文献速递腹部技术与安全CTDRDSAPET

单中心成人间活体肝移植供者与受者多次及重复放射检查的有效剂量

Effective dose for multiple and repeated radiation examinations in donors and recipients of adult-to-adult living donor liver transplants at a single center.
PubMed 文献 · Eur J Radiol · 2020-05-16

回顾性分析单中心100例供者与100例受者从2016年3月至2017年8月手术前后2年内所有放射相关检查的有效剂量。供者中位有效剂量71(30-186)mSv,受者147(32-423)mSv,主要来自CT扫描;肝细胞癌受者有效剂量195(64-423)mSv高于其他指征受者。

要点

  • 供者中位有效剂量71(30-186)mSv,受者147(32-423)mSv。
  • 肝细胞癌受者有效剂量195(64-423)mSv,高于其他指征受者。
  • 放射检查主要集中在术前最后3个月至术后第1个月。

核心结论

  • 供者和受者接受了较大的有效剂量,主要来自CT扫描。
  • 作者认为,减少有效剂量应纳入经常使用CT检查的某些活体肝移植中心未来的挑战。

研究设计与样本

  • 回顾性研究,纳入100例供者和100例受者,手术日期为2016年3月至2017年8月。
  • 分析术前1年至术后1年共2年内所有放射相关检查的剂量。
  • 平片X线、CT、透视和核医学的有效剂量分别通过蒙特卡洛软件模拟、剂量长度乘积转换因子、剂量面积乘积转换因子和放射性活度转换因子估算。
  • 放射诱发癌症风险基于ICRP风险模型评估。

关键影像表现/征象

  • 供者中位有效剂量为71(范围30-186)mSv,受者为147(32-423)mSv。
  • 肝细胞癌受者有效剂量为195(64-423)mSv,高于其他指征受者。
  • 供者和受者的放射检查主要集中在术前最后3个月至术后第1个月。

诊断标准与关键数值

  • 男性供者中位放射诱发癌症风险为0.38%,女性供者为0.48%。
  • 男性受者中位放射诱发癌症风险为0.50%,女性受者为0.58%。

临床应用与阅片要点

  • 供者和受者的有效剂量主要来自CT扫描。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the effective doses received by donors and recipients, identify effective dose contributions, and make risk assessments.

MATERIALS AND METHODS: It was a retrospective study. 100 Donors and 100 recipients were enrolled with an operative day from March 2016 to August 2017. The dose was analyzed for all radiation-related examinations over a period of 2 years, 1 year before and 1 year after the LDLT procedure. The effective doses of plain X-rays, CT, fluoroscopy, and nuclear medicine per patient were simulated by a Monte Carlo software, evaluated by the dose-length product conversion factors, evaluated by the dose-area product conversion factors, and evaluated by the activity conversion factors, respectively. The risks of radiation-induced cancer were assessed on the basis of the ICRP risk model.

RESULTS: The median effective doses were 71 (range: 30-186) mSv for donors and 147 (32-423) mSv for recipients. The radiation examinations were mainly performed in the last three months of preoperative period to first month of postoperative period for recipients and donors. The HCC recipients received a higher effective dose, 195 (64-423) mSv, than those with other indications. The median radiation-induced cancer risk was 0.38 % in male and 0.48 % in female donors and was 0.50 % in male and 0.58 % in female recipients.

CONCLUSION: Donors and recipients received a large effective dose, mainly from the CT scans. To reduce effective doses should be included in future challenges in some living donor liver transplants centers that often use CT examinations.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Chiang HW, Chuang TC, Chen CL, et al. Effective dose for multiple and repeated radiation examinations in donors and recipients of adult-to-adult living donor liver transplants at a single center. Eur J Radiol. 2020. PMID: 32447148. doi:10.1016/j.ejrad.2020.109078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。